FGF23-Klotho Axis and Fractures in Patients Without and With Early CKD: A Case-Cohort Analysis of CARTaGENE.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
17 05 2022
Historique:
received: 05 10 2021
pubmed: 10 2 2022
medline: 20 5 2022
entrez: 9 2 2022
Statut: ppublish

Résumé

Whether fibroblast growth factor-23 (FGF23) and α-Klotho are associated with fractures, especially in chronic kidney disease (CKD), remains controversial. We evaluated how FGF23, α-Klotho, and traditional mineral parameters predict fractures in individuals with and without early CKD. We conducted a stratified case-cohort analysis using CARTaGENE, a population-based survey from Quebec, Canada. Individuals aged 40 to 69 years were selected according to outcome and CKD status (non-CKD: eGFR > 60 mL/min/1.73 m2; CKD stage 3: eGFR 30-60 mL/min/1.73 m2]). Baseline levels of c-terminal FGF23 (cFGF23), α-Klotho, parathyroid hormone (PTH), phosphate, and calcium were analyzed for associations with osteoporotic fracture incidence from recruitment (2009-2010) through March 2016. Adjusted Cox models were used, and predictors were treated linearly or flexibly using splines. A total of 312 patients (159 non-CKD; 153 CKD) were included; 98 had ≥ 1 fracture at any site during a median follow up of 70 months. Compared with non-CKD, CKD patients had increased levels of cFGF23 but similar levels of α-Klotho. cFGF23 was linearly associated with increased fracture incidence (adjusted HR = 1.81 [1.71, 1.93] per doubling for all participants). The association of α-Klotho with fracture followed a U-curve (overall P = 0.019) but was attenuated by adjustment for potential mediators (bone mineral density, phosphate, PTH). PTH and phosphate also had U-shaped associations with fracture. Associations were mostly similar between non-CKD and CKD. Adjustment for cFGF23 strongly attenuated the association between CKD status and fractures. cFGF23 is associated linearly with fracture incidence while α-Klotho, PTH, and phosphate levels have a U-shaped association.

Identifiants

pubmed: 35139204
pii: 6525346
doi: 10.1210/clinem/dgac071
pmc: PMC9113817
doi:

Substances chimiques

FGF23 protein, human 0
Parathyroid Hormone 0
Phosphates 0
Fibroblast Growth Factor-23 7Q7P4S7RRE
Glucuronidase EC 3.2.1.31
Klotho Proteins EC 3.2.1.31

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2502-e2512

Subventions

Organisme : CIHR
Pays : Canada
Organisme : Fonds de Recherche du Québec - Santé
Organisme : Laval University
Organisme : FRQS
ID : 32661
Organisme : KRESCENT
ID : 150006

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Osteoporos Int. 2015 Jul;26(7):1979-87
pubmed: 25690339
Osteoporos Int. 2012 Feb;23(2):483-501
pubmed: 21336492
BMC Public Health. 2010 Jun 11;10:331
pubmed: 20540727
JBMR Plus. 2021 Mar 16;5(4):e10482
pubmed: 33869997
Nephrol Dial Transplant. 2013 Sep;28(9):2283-7
pubmed: 23787542
Osteoporos Int. 2012 Jan;23(1):143-53
pubmed: 22037972
J Clin Densitom. 2015 Apr-Jun;18(2):157-64
pubmed: 25937306
Am J Epidemiol. 2009 Jun 1;169(11):1398-405
pubmed: 19357328
J Diabetes Complications. 2020 Jan;34(1):107476
pubmed: 31708378
Clin J Am Soc Nephrol. 2014 Jul;9(7):1283-303
pubmed: 24578336
J Clin Endocrinol Metab. 2013 Aug;98(8):3323-31
pubmed: 23771921
Osteoporos Int. 2004 Oct;15(10):834-41
pubmed: 15045468
Kidney Int. 2001 Dec;60(6):2079-86
pubmed: 11737582
Eur J Radiol. 2010 Feb;73(2):360-4
pubmed: 19135327
J Am Geriatr Soc. 2016 Dec;64(12):e304-e308
pubmed: 27910102
Joint Bone Spine. 2012 Dec;79(6):544-9
pubmed: 23177912
Osteoporos Int. 2021 Nov;32(11):2145-2153
pubmed: 34021765
J Bone Miner Res. 2008 Jun;23(6):939-48
pubmed: 18282132
J Bone Miner Res. 2006 Jun;21(6):809-16
pubmed: 16753011
J Bone Miner Res. 2013 Nov;28(11):2325-32
pubmed: 23677793
Kidney Int. 2016 Jul;90(1):77-89
pubmed: 27165819
Lifetime Data Anal. 2000 Mar;6(1):39-58
pubmed: 10763560
Bone. 2019 Mar;120:548-555
pubmed: 30465918
J Am Soc Nephrol. 2019 Oct;30(10):1785-1805
pubmed: 31506289
Kidney Int. 2005 Sep;68(3):1148-53
pubmed: 16105045
Osteoporos Int. 2011 Sep;22(9):2439-48
pubmed: 21161507
J Clin Endocrinol Metab. 2011 Jul;96(7):2186-93
pubmed: 21508146
Kidney Int. 2017 Sep;92(3):599-611
pubmed: 28396120
Osteoporos Int. 2019 Oct;30(10):2019-2025
pubmed: 31190122
Osteoporos Int. 2018 Oct;29(10):2345-2353
pubmed: 29959497
Int J Epidemiol. 2012 Aug;41(4):1174-86
pubmed: 22815332
J Biol Chem. 2003 Sep 26;278(39):37419-26
pubmed: 12874285
Kidney Int. 2016 Jan;89(1):135-46
pubmed: 26535997
Bone. 2017 Jul;100:36-40
pubmed: 27890549
Nephrol Dial Transplant. 2020 Oct 1;35(10):1712-1721
pubmed: 31951261
Am J Physiol Renal Physiol. 2009 Aug;297(2):F282-91
pubmed: 19515808
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6500-5
pubmed: 11344269
Bone. 2007 Jun;40(6):1565-73
pubmed: 17350357
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
J Bone Miner Res. 2007 Mar;22(3):465-75
pubmed: 17144789
Br J Radiol. 1998 Aug;71(848):861-7
pubmed: 9828799
J Clin Endocrinol Metab. 2022 May 17;107(6):e2502-e2512
pubmed: 35139204
Kidney Int Suppl. 2009 Aug;(113):S1-130
pubmed: 19644521
Int J Epidemiol. 2013 Oct;42(5):1285-99
pubmed: 23071140
Calcif Tissue Int. 1991 Aug;49(2):107-11
pubmed: 1913288
FASEB J. 2010 Sep;24(9):3438-50
pubmed: 20466874
Kidney Int. 2011 Jun;79(12):1370-8
pubmed: 21389978
Am J Epidemiol. 2011 Sep 1;174(5):613-20
pubmed: 21749976
Nature. 2006 Dec 7;444(7120):770-4
pubmed: 17086194
Stat Biosci. 2009 May 1;1(1):32
pubmed: 20174455
Am J Kidney Dis. 2020 Oct;76(4):521-532
pubmed: 32654892
JBMR Plus. 2018 Jul 05;3(1):45-55
pubmed: 30680363
J Bone Miner Res. 2017 Jun;32(6):1182-1193
pubmed: 28177140
Kidney Int. 2003 Dec;64(6):2272-9
pubmed: 14633152
J Bone Miner Res. 2012 May;27(5):1177-85
pubmed: 22228250
Nature. 1997 Nov 6;390(6655):45-51
pubmed: 9363890
J Clin Invest. 1999 Aug;104(3):229-37
pubmed: 10430604
Nephrol Dial Transplant. 2013 Feb;28(2):352-9
pubmed: 23129826
J Bone Miner Res. 2004 Mar;19(3):429-35
pubmed: 15040831
J Bone Miner Res. 2016 Apr;31(4):742-8
pubmed: 26590361
J Bone Miner Res. 2011 Apr;26(4):857-64
pubmed: 20928885

Auteurs

Louis-Charles Desbiens (LC)

CHU de Québec Research Center, L'Hôtel-Dieu-de-Québec Hospital, Endocrinology and Nephrology Axis, Quebec City, QC G1R 2J6, Canada.
Department and Faculty of Medicine, Université Laval, Quebec City, QC G1V 5C3, Canada.

Aboubacar Sidibé (A)

CHU de Québec Research Center, L'Hôtel-Dieu-de-Québec Hospital, Endocrinology and Nephrology Axis, Quebec City, QC G1R 2J6, Canada.
Department of Social and Preventive Medicine, Faculty of Medicine, Université Laval, Quebec City, QC G1V 5C3, Canada.

Roth-Visal Ung (RV)

CHU de Québec Research Center, L'Hôtel-Dieu-de-Québec Hospital, Endocrinology and Nephrology Axis, Quebec City, QC G1R 2J6, Canada.

Fabrice Mac-Way (F)

CHU de Québec Research Center, L'Hôtel-Dieu-de-Québec Hospital, Endocrinology and Nephrology Axis, Quebec City, QC G1R 2J6, Canada.
Department and Faculty of Medicine, Université Laval, Quebec City, QC G1V 5C3, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH